Tim-Ophtal

Quick links to important sections

Tim-Ophtal

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tim-Ophtal

Property Description
Active ingredient Timolol maleate
Form Ophthalmic Solution (Eye Drops)
Pharmacological class Non-selective Beta-blocker
General purpose Management of high intraocular pressure
Origin Synthetic Propanolamine Derivative

What Type of Ophthalmic Medicine is Tim-Ophtal?

Tim-Ophtal is a prescription-only, topical ophthalmic solution administered as sterile eye drops, containing the active substance Timolol maleate. This medicine is structurally defined as a monopreparation, specifically designed for direct application to the eye. Timolol maleate belongs to the broad pharmacological class known as beta-adrenergic receptor blocking agents, or beta-blockers, which target specific receptors to modify physiological functions. The efficacy of Timolol in reducing elevated eye pressure is a primary characteristic of its pharmacological profile.

Timolol Maleate: Chemical Classification and Origin

The pharmaceutical action of Tim-Ophtal is rooted in the ingredient Timolol maleate, a synthetic compound that is chemically identified as a Propanolamine Derivative. It is prepared as a sterile, isotonic, buffered aqueous solution to ensure stability and compatibility with the delicate eye surface. Its classification as a non-selective beta-blocker means it engages both major subtypes of beta-receptors. This chemical identity distinguishes it from compounds that target only one receptor subtype, reflecting its comprehensive function in reducing ocular fluid production.

Primary Function and General Therapeutic Goal

The general purpose of this medicine is to safely and consistently achieve a reduction in elevated intraocular pressure (IOP). The physiological action involves the targeted suppression of aqueous humor formation by the ciliary body. This specific action reliably decreases the amount of fluid produced, thereby managing the critical factor of high internal eye pressure. For patients with high IOP, the consistent use of Tim-Ophtal represents a standard therapeutic approach to maintaining eye health.

What side effects are possible with Tim-Ophtal?

The safety profile of Tim-Ophtal, which contains the active ingredient Timolol maleate, is formally documented by regulatory agencies to classify potential adverse reactions. The topical ophthalmic solution is acknowledged to be systemically absorbed, meaning it can cause adverse reactions similar to those seen with oral beta-blockers, affecting multiple organ systems.

Adverse Reaction Classification

The most frequently reported local adverse reactions are signs of ocular irritation, including transient burning and stinging upon instillation. Other common reactions (4% to 10% frequency) include blurred vision and headache.

Adverse effects are categorized by System-Organ Class (SOC) and include:

  • Eye Disorders: Dry eyes, conjunctivitis, blepharitis, and decreased corneal sensitivity.
  • Cardiac/Vascular Disorders: Bradycardia (slow heart rate), arrhythmia, hypotension, and syncope.
  • Nervous System Disorders: Dizziness, depression, insomnia, and asthenia/fatigue.
  • Respiratory Disorders: Dyspnea and, rarely, severe bronchospasm.

Serious Safety Considerations

Official labeling warns of the potential for severe respiratory reactions (e.g., bronchospasm, including death in patients with asthma) and severe cardiac reactions (e.g., cardiac failure, cardiac arrest).

The medication is contraindicated in patients with specific severe pre-existing conditions, including bronchial asthma, a history of severe COPD, sinus bradycardia, second- or third-degree atrioventricular block, and overt cardiac failure. Caution is also specified for patients with diabetes mellitus due to the potential for masking signs of acute hypoglycemia. These classifications strictly define the medicine's risk profile based on its systemic effect as a beta-blocker.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Tim-Ophtal, typically resulting from accidental ingestion or excessive topical use leading to significant systemic absorption, may present with manifestations consistent with systemic beta-blockade. Officially documented clinical signs include symptomatic bradycardia (abnormally slow heart rate), hypotension (low blood pressure), and bronchospasm (airway constriction).

Documented Severe Outcomes and Required Action

Regulator-documented severe outcomes requiring immediate intervention include acute cardiac failure and profound bronchospasm. If overdosage is suspected or if severe systemic symptoms occur, immediate medical attention must be sought.

Management is officially restricted to symptomatic and supportive treatment. Regulatory documents state that no specific antidote is known and that the substance is not easily removed by hemodialysis.

Population-Specific Considerations

Specific regulatory warnings exist for use in neonates, infants, and younger children, who require extreme caution due to the potential for severe respiratory events, including apnoea (cessation of breathing) and Cheyne-Stokes breathing. Hospital monitoring may be required for severe manifestations in any population.

Therapeutic Uses of Tim-Ophtal

The core therapeutic purpose of this medication is to address elevated fluid pressure inside the eye (intraocular pressure), which is a factor linked to organ-specific functional stress in conditions like glaucoma. This section outlines the main uses and benefits.


Managing Elevated Eye Pressure and Supporting Long-Term Stability

This medication is commonly used to help manage and control the high fluid pressure inside the eye that is relevant to conditions such as primary open-angle glaucoma and ocular hypertension. It is applied in clinical settings where supportive management is appropriate to keep this pressure at an appropriate level. As a beta-blocking agent, it serves as a primary option for the management of glaucoma.

Because high eye pressure often presents with symptoms that may intensify temporarily, this treatment is relevant for conditions requiring continuous, long-term management. By managing the pressure daily, the medication is relevant for easing the overall symptom load during long-term management and may assist with addressing symptoms related to heightened physiological activity.

“This medication assists with maintaining functional stability and supports general well-being during periods of heightened physiological stress.”

Quick Fact: Relief for High Fluid Pressure

The overall goal is supportive management, providing relief that helps improve day-to-day comfort by helping to manage pressure.

Regulatory References

  1. NIH MedlinePlus overview on Ophthalmic Timolol

Eligibility and Restrictions for Use

Who Can and Cannot Use Tim-Ophtal?

This section outlines the official, label-based rules defining population eligibility for Tim-Ophtal (timolol maleate ophthalmic solution).


Populations Strictly Prohibited (Contraindicated)

Due to the risk of systemic absorption of the beta-blocker, Tim-Ophtal must not be used by patients with the following severe conditions, as established by regulatory bodies:

  • Respiratory Conditions: Bronchial asthma (or history of) and severe Chronic Obstructive Pulmonary Disease (COPD).
  • Cardiac Conditions: Sinus bradycardia (slow heart rate), second- or third-degree atrioventricular (AV) block, overt cardiac failure, or cardiogenic shock.
  • Hypersensitivity: Known allergy to timolol maleate or any of the inactive ingredients.

Use Limitations and Special Populations

Population Group Eligibility Status
Pediatric Patients Established for children 2 years of age and older. Safety and efficacy are not established for those under 2.
Pregnancy Not recommended unless considered absolutely essential.
Lactation Not recommended; patient should discontinue the drug or breastfeeding.
Metabolic/Endocrine Use with caution in diabetes or hyperthyroidism, as it may mask symptoms like hypoglycemia or tachycardia.

Use requires caution for patients with mild COPD, certain heart rhythm conditions (like first-degree heart block), severe renal impairment, and hepatic impairment.

What should I know about interactions with other medicines?

Tim-Ophtal (timolol ophthalmic) is absorbed systemically, meaning its use can lead to interactions similar to those with oral beta-blockers. Therefore, caution is essential when combining it with certain medications, primarily those that affect heart rate, blood pressure, or beta-receptor activity.

Interacting Product Category Potential Effect (Additive Systemic Effects)
Oral Beta-Blockers (e.g., Metoprolol) Increased systemic and ocular beta-blockade, potentially leading to slow heart rate or low blood pressure. Concomitant use of two topical beta-blockers is not recommended.
Calcium Antagonists (e.g., Verapamil, Diltiazem) Risk of atrioventricular conduction disturbances, left ventricular failure, and low blood pressure.
Catecholamine-Depleting Drugs (e.g., Reserpine) Additive effects that may cause marked bradycardia (slow heart rate), hypotension, and a risk of syncope.
CYP2D6 Inhibitors (e.g., Quinidine, SSRIs) Potentiated systemic beta-blockade due to reduced metabolism of timolol.
Digitalis (Cardiac Glycosides) Additive effect in prolonging atrioventricular conduction time, especially when combined with a Calcium Antagonist.
Antidiabetic Agents (Insulin, Oral Agents) Beta-blockers may mask the signs and symptoms of acute hypoglycemia (e.g., rapid pulse).

If using other topical ophthalmic medications, apply them at least ten minutes before Tim-Ophtal solution, or at least five minutes apart for most eye drops, to prevent washout. Patients taking oral beta-blockers concurrently should be closely monitored for potential additive effects.

Mechanism of Action

Blocking the Ocular beta2 Receptor Pathway

Tim-Ophtal, containing Timolol maleate, operates as a non-selective beta-adrenergic receptor antagonist. Its primary ocular function involves the competitive blockade of beta2-adrenergic receptors located on the secretory epithelium of the ciliary body. This molecular interaction prevents endogenous catecholamines from binding, thereby interrupting the signaling cascade that stimulates fluid production. This initial step of antagonism suppresses the epithelial cells' active secretory function.


Suppression of Aqueous Humor Formation

The receptor blockade functionally leads to the inhibition of the membrane-bound enzyme adenylate cyclase, resulting in a decrease in the intracellular concentration of the second messenger, cyclic Adenosine Monophosphate ( cAMP). The dampening of this key signaling mechanism reduces the activity of ion transport systems essential for the active secretion of aqueous humor components. This physiological consequence is a decrease in the rate of fluid inflow into the eye, which results in the modification of internal ocular hydrostatic dynamics.

Dosage and Administration Information

Administration of Tim-Ophtal

Tim-Ophtal is an ophthalmic solution intended for topical application to the eye. Proper administration technique is essential to ensure the solution is delivered effectively and to maintain the sterility of the product.

Preparation and Handling

Before using the eye drops, hands should be washed thoroughly with soap and water. The container should be inspected prior to use; if the tamper-evident seal is broken or missing, the product should not be used. To maintain sterility, the tip of the dropper must not touch the eye, eyelids, surrounding skin, or any other surfaces.

Application Technique

The following steps describe the general process for applying the eye drops:

  • Tilt the head back slightly or lie down.
  • Using one finger, gently pull the lower eyelid downward to create a small pocket.
  • Hold the dropper bottle over the eye with the tip pointing downward.
  • Look upward and away from the dropper.
  • Squeeze the prescribed number of drops into the conjunctival sac formed by the lower eyelid.
  • Close the eye gently without blinking or squeezing the lids shut.

Minimizing Systemic Absorption

To reduce the amount of medication absorbed into the bloodstream and to increase local residence time on the ocular surface, pressure can be applied to the nasolacrimal duct (the inner corner of the eye near the nose) for a short period immediately after instillation. Alternatively, keeping the eyelid closed for several minutes following application can achieve a similar effect.

Use with Other Ocular Medications

If more than one topical ophthalmic medication is being used, the different products should be administered at least five minutes apart. Ointments should generally be applied last to ensure they do not interfere with the absorption of liquid drops.

Contact Lens Considerations

Tim-Ophtal may contain preservatives that can be absorbed by soft contact lenses. Contact lenses should be removed prior to the application of the drops and may typically be reinserted after a short waiting period. If the eyes are irritated or if there is an underlying condition being treated, a healthcare professional can provide guidance on whether lens wear is appropriate.

Recent Clinical Evidence

Clinical Research on Tim-Ophtal (Timolol Ophthalmic Solution)

Timolol ophthalmic solution, a non-selective beta-blocker, has been a widely studied agent for managing elevated intraocular pressure (IOP) associated with open-angle glaucoma and ocular hypertension. Clinical trials generally focus on the degree of IOP reduction, the duration of its effect, and its systemic and ocular tolerability.

Efficacy in Intraocular Pressure Reduction

Multiple studies and systematic reviews have assessed the IOP-lowering effect of the drug. Its action is linked to a reduction in the production of aqueous humor within the eye. Evidence suggests a measurable decrease in IOP within 15 to 30 minutes following administration, with a maximum effect typically observed within two to four hours. The duration of this pressure-lowering effect may last for 24 hours or more. Findings related to optimal concentration have varied, with studies comparing the 0.25% and 0.5% concentrations reporting mixed results, including some data suggesting similar efficacy or an inverted dose-response curve.

Use in Combination Therapies

Timolol is frequently utilized as a component in fixed-combination therapies alongside other classes of ocular hypotensive agents, such as prostaglandin analogs or carbonic anhydrase inhibitors. Research indicates that these fixed combinations generally provide a greater reduction in IOP compared to the individual components used as monotherapies. This approach may also offer benefits in simplifying the patient's regimen.

Safety and Tolerability Profile

Due to systemic absorption following topical application, a patient's overall health profile, particularly pre-existing cardiovascular or pulmonary conditions, must be considered. Reported ocular side effects are typically localized and mild, and may include temporary stinging, burning, or blurred vision upon application. Studies examining preservative-free formulations, particularly in fixed combinations, suggest they may contribute to an improved tolerability profile and reduced symptoms of ocular surface disease compared to preserved formulations.

Frequently Asked Questions (FAQ)

Common questions about Tim-Ophtal (FAQ)


Q: Is Tim-Ophtal the same as Timolol eye drops?

Tim-Ophtal is a specific brand name for an eye drop medicine. The active ingredient in the drops is Timolol maleate, which is a type of beta-blocker. Therefore, Tim-Ophtal is a form of Timolol eye drops, which is the general name used for medicines containing this active substance.


Q: How quickly does Tim-Ophtal start working to lower eye pressure?

According to official drug information, a reduction in elevated eye pressure can usually be observed within approximately 30 minutes after a single application. The maximum pressure-lowering effect is typically measured within the first one to two hours following administration.


Q: Can Tim-Ophtal be used for other eye problems besides glaucoma?

Official regulatory documents indicate that the medicine is specifically prescribed for the management of elevated intraocular pressure associated with ocular hypertension or open-angle glaucoma. It is not currently indicated for the treatment of other specific eye diseases.


Q: Is there any difference between the brand name and the generic version?

All approved versions, both brand and generic, contain the same active ingredient (Timolol maleate) in the same concentration. However, official labeling notes that inactive ingredients, such as preservatives or other formulation components, can sometimes vary between different brand and generic products.


Q: Does the time of day matter when I use my Tim-Ophtal drops?

The effectiveness of the treatment is dependent on consistent use as directed by a prescriber. While some standard solutions may be prescribed twice daily, certain formulations, such as the gel-forming solution, are officially approved for once-daily use, usually in the morning.


Q: If I am taking blood pressure pills, is it safe to use Tim-Ophtal?

Because this medicine is absorbed systemically (into the bloodstream), official regulatory documents advise caution when combining it with medications that also affect heart rate or blood pressure. This includes oral beta-blockers and calcium channel blockers, as the combination has the potential for additive systemic effects.


Q: Can Tim-Ophtal affect my heart rate or blood pressure?

Yes, official labeling confirms that the systemic absorption of the medicine can lead to adverse reactions in the cardiovascular system. These include reports of bradycardia (a slow heart rate) and hypotension (low blood pressure).


Q: What happens to the medicine after it is absorbed into the eye?

After application, the medicine is absorbed into the systemic circulation. Regulatory information states that the medicine is primarily processed by the liver, often involving the CYP2D6 enzyme. The medicine and its resulting metabolites are then mainly excreted from the body via the urine.


Q: Do I need to keep using Tim-Ophtal even if my eye pressure seems fine?

The medicine is prescribed for the long-term management of chronic elevated eye pressure. Official patient information notes that the medicine should not be discontinued or interrupted without first consulting a prescriber, as the eye pressure could rise again without treatment.


Q: Does using Tim-Ophtal for a long time cause any long-term problems?

Clinical trials generally report that the medicine’s effectiveness in lowering eye pressure is well maintained over continuous use, sometimes for periods exceeding one year. Regulatory documents do not specifically list unique long-term toxicity or disease risks associated with prolonged use beyond the known adverse reactions.


Q: Can Tim-Ophtal cause changes to the color of my eyes or eyelashes?

While not a common side effect, regulatory reports based on postmarketing experience have included rare instances of changes to eye color and eyelash appearance with the use of this medicine.


Q: Can children or adolescents be treated with Tim-Ophtal?

Official labeling states that the use of this medicine is established and may be considered for children 2 years of age and older. However, safety and effectiveness have not been established for pediatric patients younger than 2 years of age.


Q: What should I do if the eye drops look cloudy or discolored?

The solution is officially described as colorless to nearly colorless, and some formulations may appear slightly opaque or opalescent. If the product appears distinctly cloudy, discolored, or contains foreign particles, official counseling information notes that it should not be used in this state, as this may indicate a quality issue.


Q: Are there any foods or drinks I need to avoid while on this medicine?

Official drug interaction warnings primarily focus on other medications. However, because alcohol is a central nervous system depressant and can lower blood pressure, official information suggests it may have an additive effect with this medication.


Q: How does Tim-Ophtal compare to prostaglandin analog drops (like latanoprost)?

Tim-Ophtal (a beta-blocker) and prostaglandin analogs work differently to lower eye pressure. Regulatory documents indicate that Timolol is often used in fixed-combination therapies with other classes, because these combinations have been shown to provide a greater reduction in eye pressure compared to the individual components used as monotherapies.


Q: Will I notice if the medicine is actually working to lower my eye pressure?

The action of the medicine is to lower the internal pressure of the eye, which is a process that typically causes no noticeable symptoms or sensations for the patient. The confirmation that the medicine is working must be obtained through regular intraocular pressure measurements taken by an eye care professional.


Q: Is Tim-Ophtal listed as a medication with a high risk of interaction?

Regulatory documents list several medications for which concomitant use may result in a potentiated systemic beta-blockade (e.g., slow heart rate, low blood pressure). This requires close observation and potential adjustment by a healthcare professional.


Q: Is it true that this drug can affect my ability to drive?

Yes, official patient information advises that the medicine may cause temporary adverse effects like dizziness or blurred vision. Patients are advised in official warnings to ensure their vision is clear before driving or operating machinery.


Q: Can Tim-Ophtal cause me to feel dizzy or lightheaded?

Yes, official regulatory documents list dizziness and syncope (fainting or loss of consciousness) as possible adverse reactions reported in association with the use of this medicine.


Q: Is it possible for Tim-Ophtal to affect my mood or sleep?

Yes, official regulatory labeling lists certain nervous system disorders as reported adverse reactions. These include the possibility of experiencing changes in mood, such as depression, and sleep disturbances like insomnia.


Q: Does using multiple eye drops at once cause an issue with Tim-Ophtal?

Yes, regulatory guidelines recommend separating the application of different medications if you need to use other topical eye drops. A minimum interval of 5 to 10 minutes is typically recommended to prevent the washout of one drug by the other.


Q: What's the difference between Tim-Ophtal and other types of timolol eye drops?

The primary difference lies in the formulation: Timolol is available as a standard aqueous solution and as a gel-forming solution. The latter is often prescribed for once-daily use, while the standard solution may be prescribed twice daily. Inactive ingredients and preservatives may also differ.


Q: Do any common supplements (like vitamins or herbal remedies) interact with Tim-Ophtal?

Official patient information advises patients to tell their healthcare provider about all medicines they use. This includes vitamins, minerals, and herbal supplements, because they may interact with the medicine and potentially change its effects.


Q: Is it possible to become resistant to the effects of Tim-Ophtal over time?

The pressure-lowering effect of the medicine is generally reported in clinical studies as being well maintained over long periods of continuous use. Any clinical observations regarding a change in response over time are subject to professional evaluation.


Q: Are the side effects worse when first starting Tim-Ophtal?

Official patient information notes that certain systemic effects, such as dizziness or lightheadedness, are often most likely to be observed at the beginning of treatment. These effects should be closely monitored during the initial treatment phase.


Q: Can I stop using Tim-Ophtal on my own if my pressure is low?

Official counseling information cautions against stopping the medication abruptly without first consulting the prescriber. Abrupt discontinuation of a beta-blocker, even a topical one, has been associated with adverse events in certain patient populations.


Q: Can Tim-Ophtal cause my eyes to water more than usual?

While the adverse reactions list includes 'dry eyes,' official documents also note adverse reports of 'excessive tearing' or lacrimation in postmarketing experience with this product class.


Q: Is Tim-Ophtal considered a common or standard treatment for high eye pressure?

Official regulatory documents and clinical studies indicate that this medicine has been a widely studied agent for treating elevated eye pressure. Its approval for ocular hypertension and open-angle glaucoma confirms its role as a standard therapeutic option.

How should Tim-Ophtal be stored and disposed of?

Tim-Ophtal ophthalmic solution must be stored and handled according to official regulatory specifications to maintain its stability and sterility. The medicine must be kept out of the sight and reach of children.

Condition Requirement (Official Labeling)
Temperature Store at room temperature, typically 15 C to 30 C (59 F to 86 F). Protect from freezing.
Protection Keep the container tightly closed and in its original outer carton to protect from light.
In-Use Shelf-Life The multi-dose bottle must be discarded 28 days after the first opening.
Disposal Do not dispose of the medicine via household waste or wastewater. Consult a pharmacist or local authority for proper disposal of any unused or expired product according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tim-Ophtal found in:

A-Z Index: